K Number
K080544
Device Name
UNASSIGNED
Manufacturer
Date Cleared
2008-08-14

(169 days)

Product Code
Regulation Number
880.5440
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The CT Injectable Safety Huber Needle is a device used to administer fluids from a container to a patient's vascular system through an implanted port. The CT Injectable Safety Huber Needle incorporates an active safety feature that aids in the prevention of accidental needle sticks.

The CT Injectable Safety Huber Needle is a safety needle designed with an anti-coring needle tip configuration. The primary use for Huber Needles is to deliver solutions to implanted ports. The safety feature is designed to protect the practitioner from accidental needle sticks.

The CT Injectable Safety Huber Needle is compatible with power injection procedures up to 300 psi.

Device Description

The CT Injectable Safety Huber Needle is composed of a sharpened anticoring Huber style needle for port septum access having a safety feature which is manually operated and will prevent accidental needle sticks when advanced which is connected to a conventional style extension set for attachment to standard IV/Drug infusion line sets.

The proximal end of the needle cannula is adhesively sealed to the molded housing which contains a glue well and fluid thru hole. The fluid thru hole leads to the distal end of the extension line set that is also adhesively bonded in the molded housing. The distal end of the extension tubing contains a female luer connector with removable dust cap on the proximal end creating a fluid path from the needle tip thru the female luer. The infusion set is also offered in a configuration where the extension tubing contains a Y-Site connector with removable dust cap placed midway between the needle and the female luer connector. The extension tubing contains purple pigment to indicate its use for high pressure. The Y portion of the connector is a molded female luer that is sealed with a removable dust cap. A non-removable pinch clamp is located between the female luer and needle cannula. On line sets with a Y-Site connector, two pinch clamps are present located between the female luer and the Y-Site and the Y-Site and the needle cannula. The pinch clamps are designed that when engaged, fluid flow is restricted thru the extension tubing.

The needle cannula is constructed with a Huber style anti-coring needle tip. The cannula is stainless steel and is shielded by a removable star needle quard of plastic construction.

The molded wing housing is of plastic construction and contains rigid protruding wings. The under side of the wings contain a foam comfort pad. The comfort pad is constructed with an adhesive backing which is secured to the wing housing.

The molded wing housing is snap fitted into the molded housing via a securement post. The wing housing is of plastic construction with a protruding wing designed flush with the under surface of the housing. The wing housing contains a thru hole that easily slides over the needle cannula. The wing housing contains a torsion spring that is positioned on a post and is orientated in a positioning channel. The torsion spring is in a compressed state until the molded housing is removed from the winq housing at which time the torsion spring is automatically activated. The winq housing consists of a base to which the securement bag is adhesively bonded.

The molded housing is connected to the wing housing via the securement bag. The securement bag (a polyester film lamination) is adhesively bonded to the molded housing and the wing housing. The securement bag is compressed (accordion style) between the molded housing and wing housing and is of length sufficient to activate the torsion spring and to prevent the needle tip from entering the securement bag area.

In normal operation, the molded housing is activated during removal of the needle from the patient. The wing housing is held firmly in place while the molded housing is disengaged. The molded housing is disengaged from the wing housing by grasping the elevated portion of the molded housing and sliding the molded housing in an upward direction. The molded housing will disengage from the wing housing and will advance until the torsion spring is past the needle tip at which time the torsion spring will snap over the needle access hole. Upon spring activation, there will be an audible click sound as the spring snaps against the wing housing. The securement bag prevents the molded housing from advancing off the needle cannula and the torsion spring prevents the needle from advancing out of the housing.

Prior to use, the exposed portion of the needle cannula, including the sharpened needle tip area, is coated with a silicone fluid to render the needle lubricious and to reduce the insertion (penetration) and drag force to industry acceptable values.

Each needle size has I.D. Rings located within the pinch clamp to identify the appropriate infusion rate for the noted needle gauge size. Components will be assembled by the manufacturer into standard configurations with or without the "Y-Site" and packaged.

AI/ML Overview

The provided text describes a 510(k) premarket notification for a medical device called the "CT Injectable Safety Huber Needle." This application primarily relies on substantial equivalence to a predicate device rather than extensive new studies proving acceptance criteria for the new device itself.

Here's a breakdown of the requested information based on the provided text, heavily noting what is not present:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance CriteriaReported Device Performance
Safety Feature (Aids in prevention of accidental needle sticks)The device incorporates an active safety feature that aids in the prevention of accidental needle sticks. (Design description states: "manually operated and will prevent accidental needle sticks when advanced"). The device is "identical in design, safety aspects... as the predicate PFM Medical, EZ Huber Safety Infusion Set."
Anti-coring needle tip configurationThe needle cannula is constructed with a Huber style anti-coring needle tip. The device is "identical in design... as the predicate PFM Medical, EZ Huber Safety Infusion Set."
Compatibility with power injection procedures (up to 300 psi)Pressure testing has been performed on each needle gauge size to determine pressure ratings. (Specific numerical results are not provided beyond "up to 300 psi"). The device is "identical in ... design... as the predicate PFM Medical, EZ Huber Safety Infusion Set."
Material SafetyAll materials have been used in previous cleared submissions.
SterilizationStandard sterilization procedures (not detailed, but implied by comparison to predicate). "Identical in ... sterilization... as the predicate PFM Medical, EZ Huber Safety Infusion Set."
PackagingStandard packaging (not detailed, but implied by comparison to predicate). "Identical in ... packaging... as the predicate PFM Medical, EZ Huber Safety Infusion Set."

2. Sample size used for the test set and the data provenance

  • The document states: "Clinical studies were not deemed necessary since no changes have been made to the design, packaging, sterilization or indications for use that would have any effect on the safety and effectiveness of the device when compared to the legally marketed predicate device."
  • This indicates that no formal test set (in the context of clinical studies) was used for proving acceptance criteria for this specific device as directly presented in the submission. The acceptance is based on substantial equivalence to the predicate device.
  • Data Provenance: Not applicable for new clinical data on this specific device. The reliance is on existing data and regulatory clearances of the predicate device and the materials used.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

  • Not applicable. No clinical test set data was generated for the new device.

4. Adjudication method for the test set

  • Not applicable. No clinical test set data was generated for the new device.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

  • Not applicable. This device is a manual medical instrument (Huber needle), not an AI-powered diagnostic tool.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

  • Not applicable. This device is a manual medical instrument.

7. The type of ground truth used

  • The "ground truth" for this submission is substantial equivalence to the predicate device (PFM Medical, EZ Huber Safety Infusion Set, K071846) as demonstrated through design, materials, and intended use comparison.
  • For the pressure testing, the ground truth would be established by physical measurements against a specified pressure value (e.g., 300 psi), but the detailed results of this testing, including methodology and specific values, are not provided in this summary.

8. The sample size for the training set

  • Not applicable as this is not an AI/algorithm-based device and no new clinical studies were performed. The "training set" for the predicate device's clearance would have been its own testing and clinical data, which is referenced indirectly through the substantial equivalence claim.

9. How the ground truth for the training set was established

  • Not applicable for a training set for this specific device. For the predicate device, its ground truth would have been established through its own regulatory clearance process, likely involving engineering bench testing, material biocompatibility, and potentially clinical studies or historical device performance data.

{0}------------------------------------------------

K 030544
(1)

AUG 1 4 2008

510(k) SUMMARY

Submitter Information: A.

Submitter:

Contact:

Date Prepared:

MEDCOMP® 1499 Delp Drive Harleysville, PA 19438 Tel: (215) 256-4201 Fax: 215-256-9191 Jean Callow February 26, 2008

  • B. Trade Name: Device Name: Common Name: Classification: C.F.R. Section:
    Class:

Unassigned CT Injectable Safety Huber Needle Intravascular Administration Set. FPA 880.5440 11

  • C. Predicate Device: K071846, EZ Huber Safety Infusion Set, PFM Medical, Inc.

D. Device Description:

The CT Injectable Safety Huber Needle is composed of a sharpened anticoring Huber style needle for port septum access having a safety feature which is manually operated and will prevent accidental needle sticks when advanced which is connected to a conventional style extension set for attachment to standard IV/Drug infusion line sets.

The proximal end of the needle cannula is adhesively sealed to the molded housing which contains a glue well and fluid thru hole. The fluid thru hole leads to the distal end of the extension line set that is also adhesively bonded in the molded housing. The distal end of the extension tubing contains a female luer connector with removable dust cap on the proximal end creating a fluid path from the needle tip thru the female luer. The infusion set is also offered in a configuration where the extension tubing contains a Y-Site connector with removable dust cap placed midway between the needle and the female luer connector. The extension tubing contains purple pigment to indicate its use for high pressure. The Y portion of the connector is a molded female luer that is sealed with a removable dust cap. A non-removable pinch clamp is located between the female luer and needle cannula. On line sets with a Y-Site connector, two pinch clamps are present located between the female luer and the Y-Site and the Y-Site and the needle cannula. The pinch clamps are designed that when engaged, fluid flow is restricted thru the extension tubing.

{1}------------------------------------------------

K08C542
(a)

The needle cannula is constructed with a Huber style anti-coring needle tip. The cannula is stainless steel and is shielded by a removable star needle quard of plastic construction.

The molded wing housing is of plastic construction and contains rigid protruding wings. The under side of the wings contain a foam comfort pad. The comfort pad is constructed with an adhesive backing which is secured to the wing housing.

The molded wing housing is snap fitted into the molded housing via a securement post. The wing housing is of plastic construction with a protruding wing designed flush with the under surface of the housing. The wing housing contains a thru hole that easily slides over the needle cannula. The wing housing contains a torsion spring that is positioned on a post and is orientated in a positioning channel. The torsion spring is in a compressed state until the molded housing is removed from the winq housing at which time the torsion spring is automatically activated. The winq housing consists of a base to which the securement bag is adhesively bonded.

The molded housing is connected to the wing housing via the securement bag. The securement bag (a polyester film lamination) is adhesively bonded to the molded housing and the wing housing. The securement bag is compressed (accordion style) between the molded housing and wing housing and is of length sufficient to activate the torsion spring and to prevent the needle tip from entering the securement bag area.

In normal operation, the molded housing is activated during removal of the needle from the patient. The wing housing is held firmly in place while the molded housing is disengaged. The molded housing is disengaged from the wing housing by grasping the elevated portion of the molded housing and sliding the molded housing in an upward direction. The molded housing will disengage from the wing housing and will advance until the torsion spring is past the needle tip at which time the torsion spring will snap over the needle access hole. Upon spring activation, there will be an audible click sound as the spring snaps against the wing housing. The securement bag prevents the molded housing from advancing off the needle cannula and the torsion spring prevents the needle from advancing out of the housing.

Prior to use, the exposed portion of the needle cannula, including the sharpened needle tip area, is coated with a silicone fluid to render the needle lubricious and to reduce the insertion (penetration) and drag force to industry acceptable values.

Each needle size has I.D. Rings located within the pinch clamp to identify the appropriate infusion rate for the noted needle gauge size. Components will be assembled by the manufacturer into standard configurations with or without the "Y-Site" and packaged.

{2}------------------------------------------------

KC8C544
(3)

ய் Intended Use:

The CT Injectable Safety Huber Needle is a device used to administer fluids from a container to a patient's vascular system through an implanted port. The CT Injectable Safety Huber Needle incorporates an active safety feature that aids in the prevention of accidental needle sticks.

The CT Iniectable Safety Huber Needle is a safety needle designed with an anti-coring needle tip confiquration. The primary use for Huber Needles is to deliver solutions to implanted ports. The safety feature is designed to protect the practitioner from accidental needle sticks.

The CT Injectable Safety Huber Needle is compatible with power injection procedures up to 300 psi.

ட் Performance Data:

Pressure testing has been performed on each needle gauge size to determine pressure ratings. Pressure ratings for the appropriate needle gauge is located on the I.D. Ring located within the infusion line clamp.

Clinical studies were not deemed necessary since no changes have been made to the design, packaging, sterilization or indications for use that would have any effect on the safety and effectiveness of the device when compared to the legally marketed predicate device.

G. Comparison to Predicate Devices:

The CT Injectable Safety Huber Needle is identical in design, safety aspects, packaging, sterilization and indications for use as the predicate PFM Medical, EZ Huber Safety Infusion Set. All materials have been used in previous cleared submissions.

There are no new differences in the intended use of the proposed and predicate devices which would raise any issues in the safety and effectiveness of the device.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle with its wings spread.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 1 4 2008

Ms. Jean Callow Regulatory Specialist Medcomp 1499 Delp Drive Harleysville, Pennsylvania 19438

Re: K080544

Trade/Device Name: CT Injectable Safety Huber Needle Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA Dated: August 6, 2008 Received: August 8, 2008

Dear Ms. Callow:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Page 2 - Ms. Callow

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Chiu Lin, Ph.D.

Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use

510(k) Number (if known): K080544

Device Name: CT Injectable Safety Huber Needle

Indications for Use:

The CT Injectable Safety Huber Needle is a device used to administer fluids from a container to a patient's vascular system through an implanted port. The CT Injectable Safety Huber Needle incorporates an active safety feature that aids in the prevention of accidental needle sticks.

The CT Injectable Safety Huber Needle is a safety needle designed with an anti-coring needle tip configuration. The primary use for Huber Needles is to deliver solutions to implanted ports. The safety feature is designed to protect the practitioner from accidental needle sticks.

The CT Injectable Safety Huber Needle is compatible with power injection procedures up to 300 psi.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Apturing 29, matron
(Division Sign-Off)

Division of Anesthesiology, General Hospital Infection Control, Dental Devices

Page 1 of 1

510(k) Number: _______________________________________________________________________________________________________________________________________________________________

§ 880.5440 Intravascular administration set.

(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.